Skip to main content
. 2023 Aug 19;66(10):1832–1845. doi: 10.1007/s00125-023-05988-3

Fig. 2.

Fig. 2

A summary of the observational and trial evidence for incretin-based therapies and microvascular diseases. This figure is available as part of a downloadable slideset